Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 1,000 shares at $15.34 ($15K) on 2006-10-02, disclosed to the SEC on 2006-10-03.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.25 | 200 | $3K | 19.9% |
| 2 | $15.30 | 100 | $2K | 10.0% |
| 3 | $15.31 | 100 | $2K | 10.0% |
| 4 | $15.34 | 200 | $3K | 20.0% |
| 5 | $15.35 | 100 | $2K | 10.0% |
| 6 | $15.37 | 100 |
| $2K |
| 10.0% |
| 7 | $15.43 | 200 | $3K | 20.1% |
| Total | $15.34 avg | 1,000 | $15K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |